v.bruun

TL2 Moderator · Malmö

Contributes reviews on supplier material. Based in Malmö.

Joined 22 July 2025 · last posted 2d

84 posts, newest first. Showing up to 150.

Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #14 · Compounds › Retatrutide · 26 Jul 2026 · 12 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #67 · Access › Insurance & coverage · 25 Jul 2026 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Which categories are strict and which are relaxed, honestly Replied, post #42 · Start Here › Welcome · 23 Jul 2026 · 3 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
What a reversed-phase purity number actually is Replied, post #79 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 4 likes post #78 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #107 · Analytics › Home & field testing · 21 Jul 2026 · 2 likes Picking up post #104: that is the part I would want checked first. What physical quantity does the device measure? A colorimetric or lateral-flow method typically…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 20 Jul 2026 · 10 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
Why the Start Here categories exist, and what they are not for Replied, post #15 · Start Here › Welcome · 20 Jul 2026 · 6 likes Coming back to post #13, because the follow-up matters more than the original answer. Introducing yourself is fine and requires no question. Post in this subcategory,…
Follow-up: How compounding permissions changed when supply normalised Replied, post #40 · Sourcing › Regulatory · 19 Jul 2026 · 21 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #83 · Sourcing › Red flags · 18 Jul 2026 · 6 likes I read post #81 twice before replying, because I had assumed the opposite. Anonymity: a supplier that will not disclose legal name, address, or responsible person is…
Substitution between formats during a shortage — what changed since Replied, post #11 · Access › Shortages · 13 Jul 2026 · 30 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
Common supplements people ask about, assessed one at a time Replied, post #21 · Practice › Interactions · 8 Jul 2026 · 7 likes I read post #19 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #111 · Practice › Reconstitution · 5 Jul 2026 · 12 likes Coming back to post #109, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Journal club: what we got wrong in an earlier session Replied, post #54 · Evidence › Journal club · 5 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A checklist for reading a certificate in under two minutes Replied, post #44 · Analytics › COA interpretation · 20 Jun 2026 · 19 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
CJC-1295 with and without DAC: what the modification does Replied, post #88 · Compounds › Secretagogues & GH axis · 19 Jun 2026 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
How to ask a question when you cannot say why you are asking it Replied, post #14 · Start Here › How to Ask · 15 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #29 · Compounds › Repair & healing peptides · 3 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #11 · Practice › Storage & stability · 30 May 2026 · 0 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #5 · Evidence › Journal club · 28 May 2026 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #60 · Practice › Storage & stability · 15 May 2026 · 17 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #32 · Wellbeing › Sleep · 11 May 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Insomnia at a dose step: reported experiences — the long version Replied, post #17 · Wellbeing › Sleep · 1 May 2026 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
Revisiting: What pooling buys you and what it destroys Replied, post #10 · Evidence › Meta-analyses · 30 Apr 2026 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator,…
Forced degradation studies: designing one that is informative Replied, post #40 · Analytics › Method validation · 19 Apr 2026 · 1 like post #39 is right about the mechanism and I think understates the practical bit. Stability-indicating method: one that can separate a compound from its degradation…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #20 · Evidence › Trials · 25 Mar 2026 · 25 likes post #19 answers the question as asked. The question underneath it is different. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured…
Second pass at: The topic list is dense — is that deliberate? Replied, post #109 · Meta › Site feedback · 24 Mar 2026 · 0 likes post #108 is right about the mechanism and I think understates the practical bit. Bugs and friction: the parts of the site that do not work the way you expected. Report…
[2026 update] What a purity-only report leaves out Replied, post #60 · Sourcing › Independent verification · 20 Mar 2026 · 1 like When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #87 · Lounge › Introductions · 17 Mar 2026 · 24 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
Reading an interaction checker output critically Replied, post #141 · Practice › Interactions · 9 Mar 2026 · 4 likes Coming back to post #139, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #36 · Compounds › Tirzepatide · 7 Mar 2026 · 32 likes Coming back to post #34, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
Foaming during reconstitution and whether it matters — the long version Replied, post #53 · Practice › Reconstitution · 5 Mar 2026 · 32 likes post #52 is right about the mechanism and I think understates the practical bit. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands…
Five questions in one post gets you one answer — how to split them Replied, post #24 · Start Here › How to Ask · 4 Mar 2026 · 25 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
[2026 update] Availability by country, dated, with primary sources Replied, post #35 · Access › International · 4 Mar 2026 · 29 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #29 · Sourcing › Vendor reports · 1 Mar 2026 · 17 likes Picking up post #26: that is the part I would want checked first. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #16 · Practice › Reconstitution · 17 Feb 2026 · 5 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #78 · Documentation › Wiki requests · 8 Feb 2026 · 10 likes On post #74 — agreed on the reasoning, with one qualification. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #84 · Compounds › Semaglutide · 3 Jan 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Why oral semaglutide needs an absorption enhancer at all Replied, post #58 · Compounds › Oral incretins · 13 Dec 2025 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
How to read a forest plot, properly, from scratch Replied, post #69 · Evidence › Trials · 12 Dec 2025 · 6 likes Coming back to post #67, because the follow-up matters more than the original answer. Open-label design: unblinded trials admit expectation effects. For weight-loss…
Journal club: LEADER as the historical anchor Replied, post #6 · Evidence › Journal club · 23 Nov 2025 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
[2026 update] What steady state means for the decision to escalate Replied, post #34 · Practice › Dosing & titration · 8 Nov 2025 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
Waist circumference technique and its repeatability Replied, post #12 · Outcomes › Progress reports · 1 Nov 2025 · 12 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #26 · Sourcing › Regulatory · 22 Oct 2025 · 13 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #141 · Practice › Reconstitution · 9 Oct 2025 · 7 likes Picking up post #138: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during…
Reflectance and photometric devices: precision in practice Replied, post #3 · Analytics › Home & field testing · 15 Sep 2025 · 2 likes post #2 answers the question as asked. The question underneath it is different. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #149 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes Picking up post #146: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
When a preprint is the best available evidence and we say so Replied, post #147 · Evidence › Preprints · 6 Sep 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #3 · Compounds › Semaglutide · 29 Aug 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
Follow-up: Why appetite effects are mostly central Replied, post #14 · Pharmacology › Receptor biology · 9 Aug 2025 · 5 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
A request that was declined, and the reasoning — a second dataset Replied, post #16 · Documentation › Wiki requests · 6 Aug 2025 · 1 like Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #69 · Evidence › Trials · 6 Aug 2025 · 0 likes post #68 is right about the mechanism and I think understates the practical bit. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
Sequence verification for an obscure compound: how it is done Replied, post #112 · Compounds › Other compounds · 2 Aug 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #43 · Clinical › Special populations · 18 Jul 2025 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A field-by-field walk through a certificate of analysis Replied, post #102 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes post #101 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Counter-ion content and its effect on measured mass Replied, post #82 · Analytics › Mass spectrometry · 4 Jul 2025 · 16 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #67 · Evidence › Trials · 2 Jul 2025 · 4 likes Worth separating two things that post #63 runs together. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses…
Managing an unplanned gap in supply — what changed since Replied, post #9 · Access › Shortages · 30 Jun 2025 · 20 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #10 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 23 likes post #9 is right about the mechanism and I think understates the practical bit. On integration: where the baseline is drawn matters more than most people realise. On a…
Second pass at: A payment that went through twice: how it was resolved Replied, post #3 · Sourcing › Payments · 12 Jun 2025 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #33 · Practice › Dosing & titration · 10 Jun 2025 · 2 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #34 · Compounds › Repair & healing peptides · 8 Jun 2025 · 21 likes On post #30 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #31 · Sourcing › Vendor reports · 30 May 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Cost per milligram, computed honestly across formats — the long version Replied, post #115 · Access › Pricing · 26 May 2025 · 2 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #77 · Sourcing › Red flags · 8 Apr 2025 · 14 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
Carryover and the ghost peak from last week's standard Replied, post #24 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 3 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #2 · Sourcing › Payments · 27 Mar 2025 · 1 like Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #143 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
Specification in the result column: why that is a meaningful error — the long version Replied, post #19 · Analytics › COA interpretation · 4 Mar 2025 · 7 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #15 · Evidence › Meta-analyses · 27 Jan 2025 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #66 · Analytics › COA interpretation · 27 Jan 2025 · 26 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #24 · Pharmacology › Receptor biology · 12 Jan 2025 · 7 likes post #23 answers the question as asked. The question underneath it is different. Long-term receptor changes: very little is known about what happens to receptor…
Why mass spectrometry cannot tell you about an epimer Replied, post #23 · Analytics › Mass spectrometry · 9 Jan 2025 · 9 likes I read post #21 twice before replying, because I had assumed the opposite. Purity and identity are different questions: LC-MS establishes that the species at a…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #9 · Compounds › Semaglutide · 26 Dec 2024 · 11 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Body image changing more slowly than the body Replied, post #113 · Wellbeing › Mental health · 23 Dec 2024 · 6 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #20 · Practice › Side effects · 27 Nov 2024 · 24 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
Revisiting: Moderation log format change Replied, post #38 · Meta › Announcements · 22 Nov 2024 · 27 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #105 · Compounds › Repair & healing peptides · 21 Nov 2024 · 27 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #72 · Clinical › Prescriber conversations · 17 Nov 2024 · 13 likes post #71 is right about the mechanism and I think understates the practical bit. Questions about dose: asking "how will we determine whether this dose is working for…
Buffers, pH and why a formulation is a formulation Replied, post #12 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 7 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
The C-cell question: rodent findings and their human context — what changed since Replied, post #55 · Compounds › Semaglutide · 16 Sep 2024 · 20 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Telehealth prescribing models in the US Replied, post #4 · Regional › North America · 12 Sep 2024 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Converting between mg/mL and units per dose, both directions Replied, post #7 · Practice › Reconstitution · 30 Aug 2024 · 21 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #123 · Compounds › Retatrutide · 24 Jul 2024 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Promotion criteria, and the one that stops most nominations Replied, post #18 · Documentation › Doc review · 15 Jul 2024 · 11 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.